Screener
Kiora Pharmaceuticals, Inc. KPRX Q2 2026 earnings
Reported August 7, 2026 · Before market open
EPS-$0.34Beat by $0.13
EPS estimate-$0.47
Next report
Nov 6, 2026 (in 2 months)EPS estimate-$0.38
Versus estimates
Diluted EPS
FAQ
- When did Kiora Pharmaceuticals, Inc. report Q2 2026 earnings?
- Kiora Pharmaceuticals, Inc. (KPRX) reported Q2 2026 earnings on August 7, 2026 before market open.
- What were Kiora Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
- Kiora Pharmaceuticals, Inc. reported eps of $-0.34 for Q2 2026.
- Did Kiora Pharmaceuticals, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.47 by $0.13.
- How did Kiora Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 37.0% from $-0.54.
- Where can I find Kiora Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001372514-26-000075) and the 10-Q periodic report (0001372514-26-000074) directly on SEC EDGAR. The filing index links above go to sec.gov.
